The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.
The FDA just approved a new pain medication called Journavx, which promises to treat pain without the risk of developing an addiction. 21 News is joined by Dr. Jianguo Cheng with the Cleveland Clinic ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...